[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1262378, "exercisedValue": 0, "unexercisedValue": 18056}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 713958, "exercisedValue": 0, "unexercisedValue": 5625}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 696350, "exercisedValue": 0, "unexercisedValue": 4219}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 67, "title": "Chief Technical Operations Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Pinkosky", "title": "Vice President of Drug Discovery of Early Pre-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.5, "open": 2.5, "dayLow": 2.49, "dayHigh": 2.67, "regularMarketPreviousClose": 2.5, "regularMarketOpen": 2.5, "regularMarketDayLow": 2.49, "regularMarketDayHigh": 2.67, "payoutRatio": 0.0, "forwardPE": 13.3, "volume": 6576526, "regularMarketVolume": 6576526, "averageVolume": 6748707, "averageVolume10days": 5929970, "averageDailyVolume10Day": 5929970, "bid": 2.62, "ask": 2.67, "bidSize": 43, "askSize": 61, "marketCap": 616116736, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 3.94, "allTimeHigh": 120.96, "allTimeLow": 0.69, "priceToSalesTrailing12Months": 2.0280209, "fiftyDayAverage": 2.7012, "twoHundredDayAverage": 1.7171, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": -0.34835997, "floatShares": 196463944, "sharesOutstanding": 231622825, "sharesShort": 24416434, "sharesShortPriorMonth": 24801814, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.105399996, "heldPercentInsiders": 0.0044, "heldPercentInstitutions": 0.44055998, "shortRatio": 2.9, "shortPercentOfFloat": 0.1058, "impliedSharesOutstanding": 231622825, "bookValue": -1.985, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -105831000, "trailingEps": -0.54, "forwardEps": 0.2, "52WeekChange": -0.007936537, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 2.66, "targetHighPrice": 16.0, "targetLowPrice": 1.72, "targetMeanPrice": 6.10286, "targetMedianPrice": 4.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "ebitda": -29272000, "totalRevenue": 303801984, "revenuePerShare": 1.538, "grossProfits": 130563000, "revenueGrowth": 0.691, "grossMargins": 0.42976, "ebitdaMargins": -0.09635, "operatingMargins": -0.11407, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "marketState": "CLOSED", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1762563287, "regularMarketTime": 1762549201, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 6748707, "fiftyTwoWeekLowChange": 1.97, "fiftyTwoWeekLowChangePercent": 2.8550725, "fiftyTwoWeekRange": "0.69 - 3.94", "fiftyTwoWeekHighChange": -1.28, "fiftyTwoWeekHighChangePercent": -0.3248731, "fiftyTwoWeekChangePercent": -0.7936537, "earningsTimestamp": 1762435800, "earningsTimestampStart": 1762435800, "earningsTimestampEnd": 1762435800, "earningsCallTimestampStart": 1762434000, "earningsCallTimestampEnd": 1762434000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.54, "epsForward": 0.2, "epsCurrentYear": -0.05714, "priceEpsCurrentYear": -46.55233, "fiftyDayAverageChange": -0.041199923, "fiftyDayAverageChangePercent": -0.015252451, "twoHundredDayAverageChange": 0.94290006, "twoHundredDayAverageChangePercent": 0.5491235, "priceToBook": -1.3400505, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "postMarketChangePercent": 0.3759395, "postMarketPrice": 2.67, "postMarketChange": 0.00999999, "regularMarketChange": 0.16, "regularMarketDayRange": "2.49 - 2.67", "regularMarketChangePercent": 6.4, "regularMarketPrice": 2.66, "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]